Search - tctmd.com

Displaying 981 - 1000 of 1419

Sort: Relevancy | Date

News Conference News SCCT 2018

How Will High-Sensitivity Troponin Tests Affect CTA Use in the ED?

Yael L. Maxwell

July 24, 2018

News Conference News SCCT 2018

Where Progress Meets Payment: Cardiac CT Advocates Debate the Need for an NCD

Yael L. Maxwell

July 19, 2018

News Daily News

SCAI Updates Statement on Intracoronary Diagnostic Tools

Todd Neale

July 17, 2018

Presentation

Angiography Alone vs Angiography Plus OCT to Guide PCI

July 16, 2018

News Conference News SCCT 2018

CAC Scoring Enthusiasts Frustrated Over ‘Disappointing’ USPSTF Recommendations

Yael L. Maxwell

July 16, 2018

News Daily News

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

Michael O'Riordan

July 12, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Daily News

Once Again, ISCHEMIA Trial Feels the Squeeze

Michael O'Riordan

June 29, 2018

News Daily News

Virtual Reality Begins to Make Its Mark on Cardiovascular Medicine

Caitlin E. Cox

June 25, 2018

News Daily News

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Yael L. Maxwell

June 14, 2018

News Daily News

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Michael O'Riordan

June 07, 2018

News Daily News

Similar Rate of Radial Artery Occlusion After Manual and Mechanical Compression

Michael O'Riordan

June 05, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

Caitlin E. Cox

June 01, 2018

News Daily News

Coronary CTA May Provide Novel Means of Predicting ACS Risk: ICONIC Study

L.A. McKeown

June 01, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

Michael O'Riordan

May 29, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

Presentation EuroPCR 2018

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

Presenter: Panagiotis Xaplanteris

May 23, 2018

News Conference News EuroPCR 2018

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

Yael L. Maxwell

May 22, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

Advertisement

How Will High-Sensitivity Troponin Tests Affect CTA Use in the ED?

Where Progress Meets Payment: Cardiac CT Advocates Debate the Need for an NCD

SCAI Updates Statement on Intracoronary Diagnostic Tools

Angiography Alone vs Angiography Plus OCT to Guide PCI

CAC Scoring Enthusiasts Frustrated Over ‘Disappointing’ USPSTF Recommendations

USPSTF: Insufficient Evidence to Support CAC Score, hsCRP, or ABI for Risk Assessment

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Once Again, ISCHEMIA Trial Feels the Squeeze

Virtual Reality Begins to Make Its Mark on Cardiovascular Medicine

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Similar Rate of Radial Artery Occlusion After Manual and Mechanical Compression

TCTMD’s Top 10 Most Popular Stories for May 2018

Coronary CTA May Provide Novel Means of Predicting ACS Risk: ICONIC Study

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content